Drug
Vildagliptin clinical trials
Also written Galvus, LAF237 and LAF237A.
- studies test it
- 152
- open now
- 5
- in phase 3
- 75
- first study started
- 2003
Keep track of what changes. Save the Vildagliptin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
152 studies that test it; most in 2004 (17)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 17 |
| 2005 | 17 |
| 2006 | 16 |
| 2007 | 4 |
| 2008 | 10 |
| 2009 | 7 |
| 2010 | 16 |
| 2011 | 11 |
| 2012 | 11 |
| 2013 | 10 |
| 2014 | 7 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 13
- Phase 2
- 16
- Phase 3
- 75
- Phase 4
- 49
- No phase
- 7
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 99 · Other 53
Novartis Pharmaceuticals (48) · Novartis (43) · Lund University (4) · Damanhour University (3) · Merck Sharp & Dohme LLC (2) · University of Campania Luigi Vanvitelli (2) · Sadat City University (2) · Centre Hospitalier Universitaire de Besancon (1)
Often tested with
Tested in the same studies.
Metformin (17) · Sitagliptin (7) · Dapagliflozin (4) · Pioglitazone (4) · Glimepiride (4) · Empagliflozin (3) · Saxagliptin (3) · Canagliflozin (2)
Studies
Open first, then newest update. How each study uses Vildagliptin is read from its arms, and is right about nine times in ten.
Testing it · 152
- Efficacy of Vildagliptin Versus Metformin in Patients With Polycystic Ovary SyndromeNot yet recruitingPhase 2/3Tanta UniversityNCT07811011Written as Vildagliptin (Galvus)
- Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary SyndromeRecruitingPhase 2/3October 6 UniversityNCT06142656Written as Vildagliptin 50 MG
- Clinical Trial of Vildagliptin in Early Parkinson's DiseaseNot yet recruitingNot applicableFirst Affiliated Hospital, Sun Yat-Sen UniversityNCT06951334Written as Vildagliptin 50 mg bid
- The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed ConditionsNot yet recruitingPhase 1International Bio serviceNCT06244407Written as Vildagliptin and Metformin Hydrochloride 50mg 1000 mg Film-coated Tablets
- Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DMRecruitingPhase 3Sherief Abd-ElsalamNCT03925701Written as Vildagliptin
- Prevention of Diabetes After Transplantation by Vildagliptin in the Early Post-transplant PeriodCompletedPhase 3Centre Hospitalier Universitaire de BesanconNCT02849899Written as Vildagliptin
- Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.CompletedPhase 4Fundación para la Investigación del Hospital Clínico de ValenciaNCT06851962Written as Vildagliptin (Galvus)
- Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk FactorsCompletedPhase 4Al-Azhar UniversityNCT07077525Written as Vildagliptin + Metformin
- The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder PatientsWithdrawnPhase 1/2Sadat City UniversityNCT04410341Written as Vildagliptin 50 MG
- Vildagliptin for Treatment of Antipsychotic-induced DyslipidemiaWithdrawnPhase 2Sadat City UniversityNCT04761861Written as Vildagliptin 50 MG
- Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment FailureCompletedPhase 3Laboratorios Silanes S.A. de C.V.NCT04841096Written as (A2) Glimepiride/Vildagliptin/Metformin
- Vildagliptin Versus Glimepiride in Type 2 Diabetic PatientsCompletedNot applicableDamanhour UniversityNCT06068686Written as Vildagliptin 50 MG
- Empagliflozin Versus Vildagliptin in CAD Patients With T2DMCompletedNot applicableDamanhour UniversityNCT06313008Written as Vildagliptin 50 MG
- Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet®CompletedPhase 1Reseach Laboratory of Clinical and Experimental PharmacologyNCT06103747Written as Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg)
- Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CADCompletedPhase 4Damanhour UniversityNCT03693560Written as Vildagliptin 50 mg Oral Tablet
- Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes MellitusCompletedPhase 4Getz PharmaNCT05359432Written as Vildagliptin
- The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safeyt Profile of Test Product Compared to Reference Product Will be Assessed.CompletedNot applicableAET Laboratories Private LimitedNCT05329844Written as Vildagliptin 50 MG
- Safety and Efficacy of Antidiabetic Drugs in Recently Diagnosed Patients With Type 2 DiabetesCompletedPhase 4Beni-Suef UniversityNCT04916093Written as Vildagliptin 50 MG
- Efficacy and Long-Term Safety of Vildagliptin as Add-on Therapy to Metformin in Patients With Type 2 DiabetesCompletedPhase 2/3Novartis PharmaceuticalsNCT00860288Written as Vildagliptin
- DPP4 Inhibitor on Glycemic VariabilityCompletedPhase 4University Malaysia SarawakNCT04654676Written as Vildagliptin
See all 152 studies that test Vildagliptin →
Given in every arm · 2 — Vildagliptin is usual care beside what is tested
- Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC PatientsCompletedPhase 2MedSIRNCT04300790Written as Vildagliptin
- Effects of Vildagliptine and Glimepiride on Glucose VariabilityCompletedPhase 4Seoul National University HospitalNCT01812122Written as Vildagliptin
As the comparator · 9 — what is tested is compared with Vildagliptin
- Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes MellitusRecruitingPhase 3PegBio Co., Ltd.NCT05102149Written as Vildagliptin
- Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes MellitusActive, not recruitingPhase 4National Center for Global Health and Medicine, JapanNCT05366868Written as Vildagliptin
- Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 DiabetesActive, not recruitingNot applicablePNS Hafeez - Naval HospitalNCT06913101Written as Vildagliptin 50 mg
- Comparison of Once-Weekly Trelagliptin Vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 DiabetesActive, not recruitingNot applicableLahore General HospitalNCT06889909Written as Vildagliptin 50 mg
- VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes MellitusCompletedPhase 4Novartis PharmaceuticalsNCT01528254Written as vildagliptin
- Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 DiabetesCompletedPhase 4Yaounde Central HospitalNCT02832999Written as Oral Vildagliptin
- Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.CompletedPhase 3SatRx LLCNCT03088670Written as Vildagliptin
- Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes PatientsStatus unknownPhase 4Peking UniversityNCT02999841Written as Vildagliptin
- Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With MetforminCompletedPhase 3SanofiNCT02343926Written as vildagliptin
Codes
What other systems call Vildagliptin · ClinicalTrials.gg INT006771
- MeSH (NLM) D000077597VildagliptinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) I6B4B2U96PVILDAGLIPTINConfirmed FDA, NLM, Wikidata
- RxNorm 596554Confirmed FDA, Wikidata
- Wikidata Q421042vildagliptinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66653VildagliptinOne source FDA
- DrugBank DB04876One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077597 | Vildagliptin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | I6B4B2U96P | VILDAGLIPTIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 596554 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421042 | vildagliptin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66653 | Vildagliptin | One source FDA |
| DrugBank | DB04876 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.